https://www.avient.com/news/archives?page=8
The Avient Color and Additives team for LATAM will showcase sustainable solutions and services for consumer goods and packaging at the ABRE Sustainabi
https://www.avient.com/sites/default/files/2022-07/Avient Announces Second Quarter 2022 Results_1.pdf
Our sustainability report offers a transparent look into where we are focused, how we are leading
and what this ultimately means for our many stakeholders, as well as our planet.”
See Attachment 3 for a definition and summary of special items.
See Attachment 3 for a definition and summary of special items.
https://www.avient.com/sites/default/files/resources/Polyone%2520AR.pdf
For more information about the noted
risks, see Item 1A.
On June 23, 2016, the UK held a referendum in which UK voters approved an exit from the EU.
See Note 12, Income Taxes, for additional detail.
https://www.avient.com/products/long-fiber-technology/long-fiber-technologies
Learn how long fiber composite pellets are made
Learn about the many LFT capabilities and how they translate into desirable product benefits.
https://www.avient.com/sites/default/files/2022-12/Mevopur Healthcare Bio-based Polymer Solutions Application Bulletin.pdf
KEY CHARACTERISTICS
• Available for polyethylene, polypropylene, ABS,
polycarbonate and styrenics
• Bio-content of resin carrier varies from 70% to
100% depending on polymer—calculated to
ASTM D6866 standard
• Manufactured at four ISO 13485 certified sites,
providing global consistency and security of
supply
• Documented change control beyond CAS
number, reducing risk of change
• Drop-in solutions that can be processed like
fossil-based grades on common injection
molding and extrusion machines
• Can be provided as ready-to-use pre-colored
or additive formulation
REGULATORY SUPPORT
• Raw materials tested to:
- ISO 10993-1
- USP and (incl. class VI)
- European Pharmacopeia, monograph 3.1.3/
3.1.5 (polyolefin packaging materials)
- USP (polyethylene)
- Elemental impurities as per ICH Q3D
• Registered Drug Master File (Type III) and/or
Device Master File
• Food contact according to US FDA and
APPLICATION BULLETIN
Sustainability Spotlight
Bio-polymers
Healthcare use limitations apply—see below.
For more detailed information on Mevopur uses and restrictions see www.avient.com/healthcare-use-limitations-mevopur-products or contact your Avient sales representative.
1.844.4AVIENT
www.avient.com
https://www.avient.com/sites/default/files/2023-01/Mevopur Healthcare Functional Additives for Bormed Resins Application Bulletin.pdf
MEVOPUR COLORANTS
• Standard colors in PP and PE to shorten
time-to-market
• Custom colors matched to Pantone, RAL or
other color reference
• White colorants for pharmaceutical packaging
for LDPE, HDPE and PP with opacity to reach
USP chapter
MEVOPUR FUNCTIONAL ADDITIVES
• Antistatic formulation with good flow/impact
for injection molding
• Amide- and amine-free antistatic for film
in contact with API (Active Pharmaceutical
Ingredients)
• UV blocking for transparent PP and PE
packaging to meet USP chapter
• Non-migrating friction reduction/processing
aid for PE and PP
• Laser marking/welding additive for fast,
reliable marking/assembly
• MVTR (Moisture Vapor Transmission Rate)
reduction for HDPE to improve shelf-life
• Thermal protection of the polymer during
processing
• Gamma/e-beam sterilization protection for
PP (up to 50kGy) with color compensation
for reduced yellowing
REGULATORY SUPPORT
• Raw materials tested to:
- ISO 10993-1 and USP biological
evaluation
- European Pharmacopeia 3.1.3/3.1.5
(polyolefin)
- USP (polyethylene)
- ICH Q3D elemental impurities
• Registered Drug Master File (Type III) and/or
Device Master File
• Food contact established with FDA/EU*
APPLICATION BULLETIN
* FDA/EU compliance information available upon request
Bormed™ is a registered trademark of Borealis
Healthcare use limitations apply—see below.
For more detailed information on Mevopur uses and restrictions see www.avient.com/healthcare-use-limitations-mevopur-products or contact your Avient sales representative.
1.844.4AVIENT
www.avient.com
https://www.avient.com/sites/default/files/2023-03/Mevopur Healthcare Functional Additives Nucleating Application Bulletin.pdf
REGULATORY SUPPORT
• Drug delivery devices
• Pharmaceutical packaging
• Medical equipment
KEY CHARACTERISTICS
• Manufactured at four ISO 13485 certified sites,
providing global consistency and increased
security of supply
• Documented change control beyond CAS
number level, reducing the risk of change
• Allows crystallization in semi-crystalline
polymers to begin faster and complete earlier
REGULATORY SUPPORT
• Raw materials tested to:
- ISO 10993-1 and USP biological
evaluation
- European Pharmacopeia 3.1.3/3.1.5
(polyolefin)
- USP (polyethylene)
- ICH Q3D elemental impurities
• Registered Drug Master File (Type III) and/or
Device Master File
• Food contact established with FDA/EU*
APPLICATION BULLETIN
* FDA/EU compliance information available upon request
Healthcare use limitations apply—see below.
For more detailed information on Mevopur uses and restrictions see www.avient.com/healthcare-use-limitations-mevopur-products or contact your Avient sales representative.
1.844.4AVIENT
www.avient.com
https://www.avient.com/sites/default/files/2023-05/Mevopur Healthcare Colorants and Formulations Amber for Pharma Application Bulletin.pdf
KEY CHARACTERISTICS
• Manufactured at four ISO 13485 certified sites,
providing global consistency and increased
security of supply
• Documented change control beyond CAS
number level, reducing risk of change
• Non-phthalate and formulated without
animal-derived substances
• Different tones of amber available on request
—more or less red or yellow and/or lighter
or darker
• Also available in liquid form
REGULATORY SUPPORT
• Pre-tested raw materials:
- ISO 10993-1 and USP parts
(Class VI)
- European Pharmacopeia, monograph
3.1.15, USP and elemental analysis
as per ICH Q3D
- USP criteria appearance of solution,
color
• Registered Drug Master File (Type III) by
the FDA
• Food contact compliance established with
FDA/EU*
• YBB00102002-2015 (oral liquid pharmaceutical
PET bottles) compliance support
APPLICATION BULLETIN
* FDA/EU compliance
information available
upon request
Healthcare use limitations apply—see below.
For more detailed information on Mevopur uses and restrictions see www.avient.com/healthcare-use-limitations-mevopur-products or contact your Avient sales representative.
1.844.4AVIENT
www.avient.com
https://www.avient.com/industries/consumer/consumer-discretionary/outdoor-recreation/sporting-goods
We’re here to team up with you on every step of the development process: from ideation, design and color inspiration, to ensuring durability and performance with materials and additives.
Team sports
https://www.avient.com/news/abre-sustainability-forum-include-highlights-avient-s-sustainable-color-and-additives-solutions
The Avient Color and Additives team for LATAM will showcase sustainable solutions and services for consumer goods and packaging at the ABRE Sustainability Forum in São Paulo, Brazil.
SÃO PAULO, Brazil – April 24, 2024 – Avient Corporation is pleased to announce that its Color and Additives team in Latin America (LATAM) will showcase its portfolio of specialized and sustainable materials solutions and services at the ABRE Sustainability Forum.